Last checked at 21 Jun 2013 07:00
e-Therapeutics
To present at a Proactive Investors One2One Investor Forum in Manchester on Wednesday 26th June
Oxford and Newcastle, UK, 21 June 2013- e-Therapeutics plc (AIM: ETX) announces that Dr Daniel Elger, Chief Financial Officer, will present at a Proactive Investors One2One Forum on Wednesday 26th June in Manchester.
The event will take place at the Midland Hotel, Peter Street, Manchester from 6:00pm to 7.30pm, and will be followed by a drinks reception. Further information (including a link to register participation) can be found at: http://www.proactiveinvestors.co.uk/register/event_details/195
The event is open to private investors, private client brokers, fund managers, financial institutions, hedge funds, analysts and journalists. Dr Elger will be available to speak with participants on an individual basis after the formal presentation.
Contacts:
e-Therapeutics plc Daniel Elger Tel: +44 (0) 7909 915 068 www.etherapeutics.co.uk
|
Panmure Gordon (UK) Limited Fred Walsh / Hannah Woodley / Grishma Patel Tel: +44 (0) 20 7886 2500 www.panmure.com
|
College Hill Melanie Toyne Sewell / Stefanie Bacher / Rebecca Caygill Tel: +44 (0) 20 7457 2020 Email: e-therapeutics@collegehill.com
|
About e-Therapeutics
e-Therapeutics is an AIM-listed biotechnology company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company's discovery activity is focused in cancer and degenerative diseases of the nervous system and its development effort on clinical candidates for cancer and depression. e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company please visit www.etherapeutics.co.uk.